GSK Fined $54M Over UK 'Pay-For-Delay' Deals
By Jeff Overley ( February 12, 2016, 11:03 AM EST) -- United Kingdom antitrust regulators on Friday announced a £37.6 million ($54.3 million) fine against GlaxoSmithKline PLC after concluding that the drugmaker orchestrated improper "pay-for-delay" deals to postpone generic versions of blockbuster antidepressant Seroxat....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.